PROJECT TITLE |
THE LIFEGUARD STUDY: RESPONDING TO PEOPLE IN DANGER. A FEASIBILITY STUDY TO CO-DEVELOP A COMMUNITY PHARMACY RESPONSE SERVICE FOR DOMESTIC VIOLENCE AND SUICIDAL IDEATION |
Funding body |
NIHR RfPB |
Total funding |
£370,459 |
Team |
- Dr J Solomon (School of Pharmacy, UoL)
- Prof Graham Law, CaHRU & LinCTU, University of Lincoln (UoL)
- Dr Elise Rowan, CaHRU & LinCTU, University of Lincoln (UoL)
- Dr A Latif (University of Nottingham)
- Dr P Knapp (University of York)
- Prof M Gussy (LIIRH, UoL)
- Prof D Baines (Bournemouth University)
|
Team/consortium |
- University of Lincoln
- University of Nottingham
- University of York
- Bournemouth University
|
Overarching aim |
To co-develop and evaluate the feasibility of a community pharmacy response service / intervention for people in danger from domestic violence or suicidal ideation. |
Objectives |
- To co-develop with patients / public and professionals a promotional strategy (i.e. poster displays, life-guard cards) to increase public awareness and engagement with the ‘Life-guard’ service
- To co-develop with patients / public and professionals a training package and signposting resources for pharmacy staff to enable them to respond to people in danger e.g. suicidal ideation / domestic violence
- To deliver the ‘Life-guard’ service in a purposive sample of community pharmacies to collect data on feasibility and implementation.
- To evaluate the service through the collection of pharmacy data (e.g. service uptake) ascertain public and professional views on accessibility, acceptability and service delivery
- To evaluate the potential for the intervention to be scaled up for a future trial, including economic and statistical considerations.
|
Methods |
This is a two-stage development and feasibility study to develop a complex intervention, using the MRC framework for complex interventions. |
Outcomes |
Number of referrals made to each of the referral services |
Outputs |
Peer reviewed publications:
Conference presentations: |
Impact |
The hope is that a fully developed intervention will be tested in a full clinical trial. |